Article info

Download PDFPDF

Original research
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Authors

  1. Correspondence to Dr Sandra P D'Angelo; dangelos{at}mskcc.org
View Full Text

Citation

D'Angelo SP, Bhatia S, Brohl AS, et al
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Publication history

  • Accepted April 7, 2020
  • First published May 15, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.